AI News NQ Analysis

New Launch of 'Lafoot Sole Knee' – Medical Doctor-Approved Insole Designed to Support Knees from the Sole of the Foot, Addressing Knee Discomfort Affecting 1 in 3 People Over 45

NQ Score 50/100
N1 Content Completeness 5

AI Summary (NQ-processed)

Meidai Co., Ltd. has launched 'Lafoot Sole Knee,' a new insole developed under the supervision of a medical doctor, targeting knee discomfort experienced by approximately one in three individuals over the age of 45. By improving foot balance, the product reduces knee strain by about 13%.

AI Analysis

Frequently Asked Questions

Q: What is Lafoot Sole Knee?
A: A medical doctor-approved insole designed to reduce knee strain from the soles of the feet, supporting comfortable walking through shock absorption and balance correction.
Q: How much knee strain is reduced?
A: Reduces knee strain by approximately 13% during walking (BOKEN Germantec survey). Shock absorption rate is about 93%.
Q: Which shoes can it be used in?
A: Fits most everyday shoes like sneakers, pumps, and training shoes. Available in multiple sizes.
Q: Who supervised the product?
A: Supervised by Dr. Hiroshi Katsuno, a medical doctor and certified sports physician, based on clinical foot support theory.
Q: What is the price?
A: Lafoot Sole Knee costs 3,278 JPY (tax included), available on Rakuten, Yahoo!, and the official online store.